Drugs / OCTANOL
OCTANOL
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT00016679 | May 2001 → Mar 2004 | essential tremor | National Institute of Neurological Disorders and Stroke (NINDS) | Completed | No outcome recorded |
| Phase 1 | NCT00001986 | Jan 2000 → Jan 2001 | essential tremor | National Institute of Neurological Disorders and Stroke (NINDS) | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT00102596 | Jan 2005 → Sep 2009 | essential tremor | National Institute of Neurological Disorders and Stroke (NINDS) | Completed | No outcome recorded |
| Phase 2 | NCT00080366 | Mar 2004 → Mar 2007 | essential tremor | National Institute of Neurological Disorders and Stroke (NINDS) | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OCTANOL | ChEMBL registry synonym — accepted as the source's own label CHEMBL26215 ↗ |
| Known as | 1-Octanol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00080366 ↗ |
| Known as | Octan-1-ol | ChEMBL registry synonym — accepted as the source's own label CHEMBL26215 ↗ |
| Action | Inhibit | “1-octanol is known to inhibit LTCC of olivary neurons” NCT00001986 ↗ |
| Modality | Small molecule | “1-Octanol is an long-chain alcohol with potential therapeutic benefits in treating alcohol-responsive tremors based on unknown mechanisms.” NCT00102596 ↗ |
| Route | Oral | “by mouth” NCT00016679 ↗ |